David Gionco

2015

In 2015, David Gionco earned a total compensation of $972.6K as Vice President of Finance and Chief Accounting Officer at Stemline Therapeutics, a 43% decrease compared to previous year.

Compensation breakdown

Bonus$141,245
Option Awards$364,487
Salary$284,625
Stock Awards$182,212
Total$972,569

Gionco received $364.5K in option awards, accounting for 37% of the total pay in 2015.

Gionco also received $141.2K in bonus, $284.6K in salary and $182.2K in stock awards.

Rankings

In 2015, David Gionco's compensation ranked 8,094th out of 13,638 executives tracked by ExecPay. In other words, Gionco earned more than 40.7% of executives.

ClassificationRankingPercentile
All
8,094
out of 13,638
41st
Division
Manufacturing
3,080
out of 5,190
41st
Major group
Chemicals And Allied Products
1,112
out of 1,854
40th
Industry group
Drugs
898
out of 1,528
41st
Industry
Pharmaceutical Preparations
703
out of 1,182
41st
Source: SEC filing on May 1, 2017.

Gionco's colleagues

We found three more compensation records of executives who worked with David Gionco at Stemline Therapeutics in 2015.

2015

Ivan Bergstein

Stemline Therapeutics

Chief Executive Officer

2015

Kenneth Hoberman

Stemline Therapeutics

Chief Operating Officer

2015

Eric Rowinsky

Stemline Therapeutics

Chief Medical Officer

News

You may also like